In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021. For more coverage about the pandemic, visit our coronavirus hub. 3 vaccineshave been ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out early ...

COVID-19 vaccine sales have declined, but other vaccines are still growth drivers for several companies. Top vaccine stocks for investors to consider include Pfizer and Moderna. Other vaccine ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more. Jessica was a writer on the Wellness team, with a focus on health ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...